{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T06:24:15Z","timestamp":1786947855951,"version":"build-2736575974"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL157533"],"award-info":[{"award-number":["HL157533"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Pulmonary sarcoidosis exhibits heterogeneous clinical trajectories ranging from self-limited disease resolution to chronic progressive fibrosis, yet reliable biomarkers capable of distinguishing these disease patterns remain lacking. Whether longitudinal CT-defined sarcoidosis phenotypes are associated with distinct circulating molecular signatures remains unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed high-throughput plasma proteomics (SomaScan 11K) in participants with pulmonary sarcoidosis classified into longitudinal chest CT-defined progressive fibrosis, progressive nodular inflammatory disease, or resolving disease trajectories, along with healthy controls. CT phenotypes were assigned based on predefined longitudinal changes in reticulation, traction bronchiectasis, nodular involvement, and mediastinal lymphadenopathy across serial CT scans. One plasma sample per participant was selected from the study visit corresponding to the CT time point at which criteria for the assigned longitudinal phenotype were met. Principal component analysis, hierarchical clustering, pathway enrichment, and correlation-based analyses linking protein expression to quantitative CT features were used to evaluate whether distinct longitudinal CT phenotypes were associated with divergent proteomic signatures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Principal component analysis and hierarchical clustering suggested partial segregation by CT-defined phenotype. Longitudinal CT phenotypes were associated with distinct pathway-level proteomic signatures, with progressive fibrosis enriched for epithelial\u2013mesenchymal transition signaling, and progressive nodular inflammatory disease enriched for mTORC1, MYC, oxidative phosphorylation, adipogenesis, and fatty acid metabolism pathways. Correlation analyses showed coordinated protein-expression patterns associated with fibrotic CT features and mediastinal lymph node enlargement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>These findings suggest that longitudinal CT-defined fibrotic and inflammatory sarcoidosis phenotypes are associated with distinct pathway-level proteomic signatures. This pilot study provides preliminary proof-of-concept evidence that integrating longitudinal CT imaging phenotypes with plasma proteomics may serve as a framework for future mechanistic studies and biomarker discovery in pulmonary sarcoidosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1888839","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T05:25:52Z","timestamp":1786944352000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Pilot study identifying distinct circulating proteomic profiles associated with longitudinal CT-defined fibrotic and inflammatory sarcoidosis"],"prefix":"10.3389","volume":"17","author":[{"given":"Vibha","family":"Shastry","sequence":"first","affiliation":[{"name":"Department of Medicine, University of California, San Francisco","place":["San Francisco, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia M.","family":"Leach","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Geisel School of Medicine, Dartmouth College","place":["Lebanon, NH, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett M.","family":"Elicker","sequence":"additional","affiliation":[{"name":"Department of Radiology & Biomedical Imaging, University of California, San Francisco","place":["San Francisco, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura L.","family":"Koth","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Francisco","place":["San Francisco, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.7774","article-title":"Diagnosis and treatment of pulmonary sarcoidosis: a review","volume":"327","author":"Belperio","year":"2022","journal-title":"Jama"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/mcp.0000000000000893","article-title":"Novel insights in fibrotic pulmonary sarcoidosis","volume":"28","author":"Comes","year":"2022","journal-title":"Curr Opin Pulm Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202002-0251st","article-title":"Diagnosis and detection of sarcoidosis. An official American Thoracic Society clinical practice guideline","volume":"201","author":"Crouser","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/nejmra2101555","article-title":"Challenges of sarcoidosis and its management","volume":"385","author":"Drent","year":"2021","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2017.11.030","article-title":"The pathogenesis of pulmonary sarcoidosis and implications for treatment","volume":"153","author":"Patterson","year":"2018","journal-title":"Chest"},{"key":"B6","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S2213-2600(18)30064-X","article-title":"Pulmonary sarcoidosis","volume":"6","author":"Spagnolo","year":"2018","journal-title":"Lancet Respir Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01443","article-title":"Biomarkers in the diagnosis and prognosis of sarcoidosis: current use and future prospects","volume":"11","author":"Kraaijvanger","year":"2020","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(13)60680-7","article-title":"Sarcoidosis","volume":"383","author":"Valeyre","year":"2014","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-2600(23)00267-9","article-title":"High-resolution CT phenotypes in pulmonary sarcoidosis: a multinational Delphi consensus study","volume":"12","author":"Desai","year":"2024","journal-title":"Lancet Respir Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1148\/rg.306105512","article-title":"Pulmonary sarcoidosis: typical and atypical manifestations at high-resolution CT with pathologic correlation","volume":"30","author":"Criado","year":"2010","journal-title":"Radiographics"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41374-022-00830-7","article-title":"High-throughput proteomics: a methodological mini-review","volume":"102","author":"Cui","year":"2022","journal-title":"Lab Invest"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13030681","article-title":"Application of the human proteome in disease, diagnosis, and translation into precision medicine: current status and future prospects","volume":"13","author":"Xie","year":"2025","journal-title":"Biomedicines"},{"key":"B13","doi-asserted-by":"crossref","first-page":"6903","DOI":"10.1038\/s41467-023-42682-9","article-title":"Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosis","volume":"14","author":"\u00c5kesson","year":"2023","journal-title":"Nat Commun"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2020-0070ps","article-title":"Application of proteomics in sarcoidosis","volume":"63","author":"Guerrero","year":"2020","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/resp.13383","article-title":"Proteomics: clinical and research applications in respiratory diseases","volume":"23","author":"Norman","year":"2018","journal-title":"Respirology"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00621-2021","article-title":"The landscape of transcriptomic and proteomic studies in sarcoidosis","volume":"8","author":"Bhargava","year":"2022","journal-title":"ERJ Open Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"13282","DOI":"10.1038\/s41598-020-69281-8","article-title":"Novel protein pathways in development and progression of pulmonary sarcoidosis","volume":"10","author":"Bhargava","year":"2020","journal-title":"Sci Rep"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2026-119604","article-title":"Molecular characterisation of progressive pulmonary sarcoidosis: protocol for a longitudinal multi-centre study to develop peripheral blood circulating biomarkers for predicting pulmonary sarcoidosis progression","volume":"16","author":"Bhargava","year":"2026","journal-title":"BMJ Open"},{"key":"B19","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1080\/1744666x.2019.1568240","article-title":"Clinically-useful serum biomarkers for diagnosis and prognosis of sarcoidosis","volume":"15","author":"Ramos-Casals","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/8565423","article-title":"Prognostic biomarkers of sarcoidosis: a comparative study of serum chitotriosidase, ACE, lysozyme, and KL-6","volume":"2019","author":"Bergantini","year":"2019","journal-title":"Dis Markers"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-019-1263-z","article-title":"Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis","volume":"21","author":"Bennett","year":"2020","journal-title":"Respir Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2009.09.034","article-title":"Plasma chitotriosidase and CCL18 as surrogate markers for granulomatous macrophages in sarcoidosis","volume":"411","author":"Boot","year":"2010","journal-title":"Clin Chim Acta"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-017-0037-y","article-title":"Clinical and biological insights from the University of California San Francisco prospective and longitudinal cohort","volume":"195","author":"Benn","year":"2017","journal-title":"Lung"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2463062200","article-title":"Idiopathic pulmonary fibrosis: physiologic tests, quantitative CT indexes, and CT visual scores as predictors of mortality","volume":"246","author":"Best","year":"2008","journal-title":"Radiology"},{"key":"B25","doi-asserted-by":"crossref","DOI":"10.1378\/chest.06-2553","article-title":"Chronic interstitial pneumonia in silicosis and mix-dust pneumoconiosis: its prevalence and comparison of CT findings with idiopathic pulmonary fibrosis","volume":"131","author":"Arakawa","year":"2007","journal-title":"Chest"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jesp.2013.03.013","article-title":"Detecting outliers: do not use standard deviation around the mean, use absolute deviation around the median","volume":"49","author":"Leys","year":"2013","journal-title":"J Exp Soc Psychol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008123","article-title":"Reduced expression of annexin A2 is associated with impaired cell surface fibrinolysis and venous thromboembolism","volume":"137","author":"Fassel","year":"2021","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1038\/s41598-018-19828-7","article-title":"Down-regulation of guanylate binding protein 1 causes mitochondrial dysfunction and cellular senescence in macrophages","volume":"8","author":"Qiu","year":"2018","journal-title":"Sci Rep"},{"key":"B29","doi-asserted-by":"publisher","first-page":"4365","DOI":"10.1038\/s41467-025-59644-y","article-title":"Endothelial major vault protein alleviates vascular remodeling via promoting Parkin-mediated mitophagy","volume":"16","author":"Jiang","year":"2025","journal-title":"Nat Commun"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2015.10.007","article-title":"Major vault protein regulates cell growth\/survival signaling through oxidative modifications","volume":"28","author":"Das","year":"2016","journal-title":"Cell Signal"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00553.2016","article-title":"Annexin A2 contributes to lung injury and fibrosis by augmenting factor Xa fibrogenic activity","volume":"312","author":"Schuliga","year":"2017","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1021\/pr1009355","article-title":"Comparative proteomic analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF) and lung transplant donor lungs","volume":"10","author":"Korfei","year":"2011","journal-title":"J Proteome Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/ni.3655","article-title":"Chronic signaling via the metabolic checkpoint kinase mTORC1 induces macrophage granuloma formation and marks sarcoidosis progression","volume":"18","author":"Linke","year":"2017","journal-title":"Nat Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.cell.2016.09.054","article-title":"DNA damage signaling instructs polyploid macrophage fate in granulomas","volume":"167","author":"Herrtwich","year":"2016","journal-title":"Cell"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/bf03256611","article-title":"Idiopathic pulmonary fibrosis","volume":"389","author":"Richeldi","year":"2017","journal-title":"Lancet"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1172\/jci39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J Clin Invest"},{"key":"B37","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J Pathol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/jcp.22783","article-title":"PAI-1 in tissue fibrosis","volume":"227","author":"Ghosh","year":"2012","journal-title":"J Cell Physiol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2019-0341ed","article-title":"PAI-1: a new target for controlling lung-cell senescence and fibrosis","volume":"62","author":"Adnot","year":"2020","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12643","article-title":"Serpine 1 induces alveolar type II cell senescence through activating p53-p21-Rb pathway in fibrotic lung disease","volume":"16","author":"Jiang","year":"2017","journal-title":"Aging Cell"},{"key":"B41","article-title":"Matrilin-2, an extracellular adaptor protein, is needed for the regeneration of muscle, nerve and other tissues","volume":"10","author":"Korpos","year":"2015","journal-title":"Neural Regener Res"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2016.12.022","article-title":"Matrilin-2 regulates proliferation, apoptosis and cell cycle during radiation-induced injury in HPAEpiC cell","volume":"485","author":"Luo","year":"2017","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1888839\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T05:25:54Z","timestamp":1786944354000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1888839\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":42,"alternative-id":["10.3389\/fimmu.2026.1888839"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1888839","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"article-number":"1888839"}}